Chhattisgarh Pharma Firm Slapped Recall Notice Over Defective Paracetamol Tablets
Chhattisgarh: A Mahasamund-based pharma firm, 9M India Ltd., has been issued a formal notice by the Chhattisgarh Medical Services Corporation Limited (CGMSCL), after serious defects were identified in a consignment of paracetamol tablets supplied to government health facilities.
As per recent Amar Ujala report, following complaints from CGMSCL’s drug warehouses and health units, quality testing was conducted on 500 mg and 650 mg tablets manufactured in 2024. Laboratory analysis confirmed that the tablets were of compromised quality, with black spots observed on the surface, rendering them unfit for human consumption.
In response, CGMSCL has directed the company to recall all affected batches immediately and ensure replacement with new stock that meets prescribed quality standards, reports Amar Ujala.
The corporation also warned that non-compliance with these instructions will attract strict action under tender regulations, with the company held fully accountable for any public health risks.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.